Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invuity developed and commercialized advanced surgical visualization and illumination devices using its proprietary Eigr "Intelligent Photonics" technology. These products improved access and visibility in minimally invasive surgeries across multiple specialties. The company experienced rapid revenue growth prior to being acquired by Stryker in late 2018 for approximately $190 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invuity.